7 completed, 1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Epividian: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatitis C Diagnosis to Treatment Management Hepatitis C Treatment Alerts in CHORUS™, Standard of Care - Hepatitis C | Completed | Epividian | 1063 | 2023-01-16 | 2024-02-16 | |
| Hepatitis C Screening Alerts Hepatitis C Screening Alerts in CHORUS™, Standard of Care - Hepatitis C | Completed | Epividian | 125706 | 2023-01-16 | 2024-02-16 | |
| External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA Ibalizumab - HIV-1-infection | Completed | Epividian | 141 | 2022-08-05 | 2023-09-07 | |
| Cabenuva Injection Tracking in CHORUS Cabenuva Scheduling Alerts in the Retention & Huddle modules of the CHORUS App - HIV Infections | Not applicable | Completed | Epividian | 37 | 2021-10-01 | 2025-02-25 |
| COVID-19 Quantitative Antibody Titers & Booster Vaccinations Observational - COVID-19, COVID-19 Vaccines | Completed | Epividian | 825 | 2020-12-11 | 2022-07-27 | |
| Epividian / AHF: Positive Pathways - HIV Retention in Care Alert to provider - HIV/AIDS | Completed | Epividian | 10521 | 2020-10-05 | 2025-02-25 | |
| Charlotte Retention in Care Study Alert to provider - HIV I Infection | Completed | Epividian | 6500 | 2018-07-01 | 2021-11-04 | |
| Observational Pharmaco-Epidemiology Research & Analysis Non-interventional (observational only) - Chronic Disease, HIV/AIDS | Recruiting | Epividian | 2000000 | 2013-12-01 | 2026-09-11 |
Acquired Immunodeficiency Syndrome (2) · Hepatitis C (2) · COVID-19 (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · HIV Infections (1) · Inflammatory Bowel Diseases (1) · Liver Diseases (1) · Neurodegenerative Diseases (1) · Rheumatic Diseases (1)
Standard of Care (2) · Watchful Waiting (1) · ibalizumab (1)
United States (8)
Michael Wohlfeiler, MD (3) · Douglas Dieterich, MD (1) · Michael Leonard, MD (1) · Ricky Hsu, MD (1)